Position in AMGN
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$3,816,382
+$2,149,669 QoQ
Shares Held
10,539
+122.5% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.32%
of 13F equity value
Holder Rank
#954
of 3,140 holders
Holding Since
Mar 2024
9 quarters on record
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Simplicity Wealth,LLC holds $64,075,335 across 13 Drug Manufacturers - General names. AMGN ranks #5 (6.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
81,682 | $20,554,458 | |
| 2 | JNJ |
Johnson & Johnson
|
53,196 | $13,510,188 | |
| 3 | LLY |
ELI LILLY & Co
|
9,693 | $11,626,075 | |
| 4 | MRK |
Merck & Co., Inc.
|
53,267 | $6,844,809 | |
| 5 | AMGN |
Amgen Inc
This page
|
10,539 | $3,816,382 | |
| 6 | PFE |
Pfizer Inc
|
109,120 | $2,627,609 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
10,730 | $1,355,628 | |
| 8 | NVS |
Novartis AG
|
5,984 | $937,812 |
All Filings in AMGN
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,816,382 | 10,539 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $1,666,713 | 4,737 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $1,443,764 | 4,411 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $971,614 | 3,443 | Shares | Sole | 2025-10-30 | |
| 2025-06-30 | $1,434,580 | 5,138 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $390,060 | 1,252 | Shares | Sole | 2025-04-15 | |
| 2024-09-30 | $511,347 | 1,587 | Shares | Sole | 2024-10-10 | |
| 2024-06-30 | $7,087,615 | 22,684 | Shares | Sole | 2024-07-10 | |
| 2024-03-31 | $6,319,580 | 22,227 | Shares | Sole | 2024-04-24 | |
| No filing history on record for this holder in this stock. | ||||||